The whistleblowers who helped to build the case for prosecuting Johnson & Johnson for illegal marketing of Risperdal will take home nearly $168 million of the $2.2 billion the company will pay. Judith Doetterl stayed undercover for nine years while the case played out. “Here’s a 34-year-old woman with a tremendous job, putting her career on the line and wearing a wire, all in order to do the right thing,” said Doetterl’s lawyer.
Of further interest:
Antipsychotic Risperdal Slapped with $2 Billion Dementia Penalty (Alzheimer’s & Dementia Weekly)
$168 million payout to Johnson & Johnson whistleblowers (CNN Money)
J&J whistleblowers to collect record $168M share of DoJ settlement (Fierce Pharma)
Post-DoJ settlement, GlaxoSmithKline toes the line in Breo launch (Fierce Pharma)